Wave Life Sciences WVE Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's other income, net (note 6)?
- Wave Life Sciences (WVE) reported other income, net (note 6) of -$80K in Q1 2026.
- How has Wave Life Sciences's other income, net (note 6) changed year-over-year?
- Wave Life Sciences's other income, net (note 6) decreased by 256.9% year-over-year, from $51K to -$80K.
- What is the long-term trend for Wave Life Sciences's other income, net (note 6)?
- Over 3 years (2021 to 2025), Wave Life Sciences's other income, net (note 6) has grown at a -51.2% compound annual growth rate (CAGR), from $4.54M to $527K.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.